エイレアの世界市場レポート 2025

エイレア市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で107億5,000万米ドルに成長します。予測期間の成長は、新たな治療適応症、バイオシミラー競合のイントロダクション、認知度・診断度の向上、実臨床エビデンスと市販後調査、より少ない頻度の注射に対する患者の嗜好などに起因すると考えられます。予測期間における主な動向としては、画像技術の進歩、遠隔医療と遠隔モニタリング、患者支援プログラム、ドラッグデリバリー技術の進歩、網膜画像技術、新規適応症の臨床試験などが挙げられます。

エイレア市場の拡大は、眼疾患の有病率の増加によってもたらされています。眼疾患には、適切な眼機能を妨げ、視力の明瞭性に影響を与える様々な眼疾患が含まれます。湿性加齢黄斑変性（AMD）や緑内障などの眼疾患に対応する治療薬であるエイレアは、弱った血管の成長を担うタンパク質を阻害し、血管の閉塞による網膜の腫れを抑えることで効果を発揮します。2022年10月現在、BrightFocus Foundationの報告によると、世界の緑内障患者数は約8,000万人と推定され、2040年には1億1,100万人を超えると予想されています。このような眼疾患の急増は、エイレアの需要拡大の主要な推進力となっています。

エイレア市場の成長が期待される背景には、世界の老人人口の増加があります。この人口動態の変化は、エイレアで治療される疾患の有病率の増加に大きく寄与しており、高齢者は眼疾患を発症するリスクが高いからです。2022年10月の世界保健機関（WHO）の統計では、60歳以上の世界人口の大幅な増加が予測されており、2020年の10億人から2022年には約14億人に増加すると予測されています。この動向は今後も続くと予想され、2030年には世界の6人に1人が60歳以上の高齢者になるという試算もあります。したがって、この人口動態の変化は、エイレア市場の拡大を促進する大きなきっかけとなっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界エイレア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のエイレア市場：成長率分析
• 世界のエイレア市場の実績：規模と成長, 2019-2024
• 世界のエイレア市場の予測：規模と成長, 2024-2029, 2034F
• 世界エイレア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のエイレア市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルドシリンジパッケージ
• バイアルパッケージ
• 世界のエイレア市場障害によって、実績と予測, 2019-2024, 2024-2029F, 2034F
• 滲出型加齢黄斑変性症（AMD）
• 糖尿病網膜症
• その他の疾患
• 世界のエイレア市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 小売薬局
• その他の用途
• 世界のエイレア市場、プレフィルドシリンジパッケージのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与プレフィルドシリンジ
• 多用量プレフィルドシリンジ
• 世界のエイレア市場バイアルパッケージのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与バイアル
• マルチドーズバイアル

第7章 地域別・国別分析

• 世界のエイレア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のエイレア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• エイレア市場：競合情勢
• エイレア市場：企業プロファイル
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Amgen Inc.
• Sanofi S.A.
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Biogen Inc.
• Alcon Inc.
• Johnson & Johnson
• Eli Lilly and Company
• Genentech Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company
• Samsung Bioepis Co. Ltd.
• Lupin Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• エイレア市場2029：新たな機会を提供する国
• エイレア市場2029：新たな機会を提供するセグメント
• エイレア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Eylea is a drug administered through eye injections designed to slow vision loss and address certain diseases by inhibiting the leaking and growth of fluid from abnormal blood vessels at the back of the eye. It is primarily used in the treatment of age-related macular degeneration (AMD).

The main packaging formats for Eylea include prefilled syringe packages and vial packages. Prefilled syringe packages are disposable syringes that come pre-loaded with the drug, streamlining the administration process. Eylea is employed in the treatment of conditions such as wet age-related macular degeneration (AMD), diabetic retinopathy, and other disorders. These medications are typically distributed through hospitals, retail pharmacies, and other healthcare applications.

The eylea market research report is one of a series of new reports from The Business Research Company that provides eylea market statistics, including eylea industry global market size, regional shares, competitors with an eylea market share, detailed eylea market segments, market trends and opportunities, and any further data you may need to thrive in the eylea industry. This eylea market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eylea market size has grown steadily in recent years. It will grow from $8.09 billion in 2024 to $8.49 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to diabetic macular edema (DME) prevalence, clinical efficacy and safety profile, competition with other anti-VEGF therapies, approval for various retinal conditions, shift towards intravitreal injections.

The eylea market size is expected to see strong growth in the next few years. It will grow to $10.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to emerging therapeutic indications, introduction of biosimilar competition, increasing awareness and diagnosis, real-world evidence and post-market studies, patient preference for less frequent injections. Major trends in the forecast period include advancements in imaging technologies, telemedicine and remote monitoring, patient assistance programs, advances in drug delivery technologies, retinal imaging technologies, clinical trials for new indications.

The expansion of the Eylea market is being driven by the increasing prevalence of ocular diseases, which encompasses various eye conditions hindering proper eye function and impacting vision clarity. Eylea, a treatment addressing ocular diseases such as wet age-related macular degeneration (AMD) and glaucoma, works by impeding the protein responsible for the growth of weakened blood vessels and reducing retina swelling caused by vessel blockages. As of October 2022, reports from the BrightFocus Foundation estimated around 80 million global cases of glaucoma, expected to surpass 111 million by 2040. This upsurge in ocular diseases is a key driver for the growing demand for Eylea.

The anticipated growth of the Eylea market is attributed to the rising global geriatric population, generally aged 65 and above. This demographic shift significantly contributes to the increasing prevalence of conditions treated by Eylea, as older individuals are at a higher risk of developing ocular diseases. Statistics from the World Health Organization in October 2022 predicted a considerable rise in the global population aged 60 and above, projecting an increase from 1 billion in 2020 to approximately 1.4 billion by 2022. This trend is expected to continue, with estimates indicating that by 2030, 1 in 6 people globally will be aged 60 or older. Hence, this demographic shift is a major catalyst driving the expansion of the Eylea market.

A prominent trend in the Eylea market involves extensive research and development efforts aimed at innovative solutions. Key players, such as Regeneron Pharmaceuticals, Inc., are committed to pioneering technical advancements in Eylea. In August 2023, Regeneron Pharmaceuticals secured approval from the US FDA for Eylea HD (aflibercept) injection 8 mg. This approval extends Eylea's application to treat patients with wet AMD, diabetic macular edema (DME), and diabetic retinopathy (DR). The treatment regimen involves an initial phase of injections every four weeks for three months across all indications, followed by adjusted intervals of every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy. This signifies the industry's dedication to evolving treatment strategies and enhancing patient care through continual research and development initiatives.

Major players in the eylea market are strategically focusing on the development of biologic medications, specifically biosimilars akin to aflibercept, to secure a competitive edge within the industry. Aflibercept Biosimilars represent biologically comparable iterations of the reference drug aflibercept, engineered to exhibit no clinically significant disparities and offer a cost-efficient substitute for treating certain eye-related conditions. For instance, in September 2023, Biocon Biologics Ltd., an India-based biopharmaceutical company, secured marketing authorization from the European Commission (EC) for YESAFILI, a biosimilar version of Aflibercept, within the European Union (EU). The EC's endorsement, following a favorable review by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in July, signifies YESAFILI's compatibility in quality, safety, and efficacy with the reference product Eylea (aflibercept). YESAFILI is specifically designed as an ophthalmological treatment for various eye conditions.

In January 2023, Coherus BioSciences Inc., a US-based biopharmaceutical entity, acquired exclusive commercialization rights to the Eylea Biosimilar Candidate from Klinge Biopharma GmbH for $32.5 million. This acquisition underscores Coherus BioSciences' commitment to expanding treatment options and improving access for both physicians and patients seeking high-quality and affordable alternatives to anti-VEGF therapies across the healthcare spectrum. Klinge Biopharma GmbH, a Germany-based pharmaceutical company, specializes in providing ocular disease drugs such as Eylea Biosimilar. This strategic move allows Coherus BioSciences to fortify its portfolio in offering alternative treatments while expanding its market reach in ocular care.

Major companies operating in the eylea market include Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Biogen Inc., Alcon Inc., Johnson & Johnson, Eli Lilly and Company, Genentech Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Samsung Bioepis Co. Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.

North America was the largest region in the eylea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the eylea market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eylea market consists of sales of single-dose vials and single-dose prefilled syringes of Eylea. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eylea Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eylea market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eylea ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eylea market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Prefilled Syringe Package; Vial Package
• 2) By Disorder: Wet Age-Related Macular Degeneration (AMD); Diabetic Retinopathy; Other Disorders
• 3) By Application: Hospitals; Retail Pharmacy; Other Applications
• Subsegments:
• 1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes; Multi-Dose Prefilled Syringes
• 2) By Vial Package: Single-Dose Vials; Multi-Dose Vials
• Companies Mentioned: Regeneron Pharmaceuticals Inc.; Bayer AG; Novartis AG; Roche Holding AG; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Eylea Market Characteristics

3. Eylea Market Trends And Strategies

4. Eylea Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Eylea Growth Analysis And Strategic Analysis Framework

• 5.1. Global Eylea PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Eylea Market Growth Rate Analysis
• 5.4. Global Eylea Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Eylea Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Eylea Total Addressable Market (TAM)

6. Eylea Market Segmentation

• 6.1. Global Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prefilled Syringe Package
• Vial Package
• 6.2. Global Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wet Age-Related Macular Degeneration (AMD)
• Diabetic Retinopathy
• Other Disorders
• 6.3. Global Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Retail Pharmacy
• Other Applications
• 6.4. Global Eylea Market, Sub-Segmentation Of Prefilled Syringe Package, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Prefilled Syringes
• Multi-Dose Prefilled Syringes
• 6.5. Global Eylea Market, Sub-Segmentation Of Vial Package, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Vials
• Multi-Dose Vials

7. Eylea Market Regional And Country Analysis

• 7.1. Global Eylea Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Eylea Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eylea Market

• 8.1. Asia-Pacific Eylea Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eylea Market

• 9.1. China Eylea Market Overview
• 9.2. China Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eylea Market

• 10.1. India Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eylea Market

• 11.1. Japan Eylea Market Overview
• 11.2. Japan Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eylea Market

• 12.1. Australia Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eylea Market

• 13.1. Indonesia Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eylea Market

• 14.1. South Korea Eylea Market Overview
• 14.2. South Korea Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eylea Market

• 15.1. Western Europe Eylea Market Overview
• 15.2. Western Europe Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eylea Market

• 16.1. UK Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eylea Market

• 17.1. Germany Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eylea Market

• 18.1. France Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eylea Market

• 19.1. Italy Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eylea Market

• 20.1. Spain Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eylea Market

• 21.1. Eastern Europe Eylea Market Overview
• 21.2. Eastern Europe Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eylea Market

• 22.1. Russia Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eylea Market

• 23.1. North America Eylea Market Overview
• 23.2. North America Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eylea Market

• 24.1. USA Eylea Market Overview
• 24.2. USA Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eylea Market

• 25.1. Canada Eylea Market Overview
• 25.2. Canada Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eylea Market

• 26.1. South America Eylea Market Overview
• 26.2. South America Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eylea Market

• 27.1. Brazil Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eylea Market

• 28.1. Middle East Eylea Market Overview
• 28.2. Middle East Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eylea Market

• 29.1. Africa Eylea Market Overview
• 29.2. Africa Eylea Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Eylea Market, Segmentation By Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Eylea Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eylea Market Competitive Landscape And Company Profiles

• 30.1. Eylea Market Competitive Landscape
• 30.2. Eylea Market Company Profiles
  • 30.2.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Eylea Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. Sanofi S.A.
• 31.3. AbbVie Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Merck & Co. Inc.
• 31.6. GlaxoSmithKline plc
• 31.7. Biogen Inc.
• 31.8. Alcon Inc.
• 31.9. Johnson & Johnson
• 31.10. Eli Lilly and Company
• 31.11. Genentech Inc.
• 31.12. AstraZeneca plc
• 31.13. Bristol-Myers Squibb Company
• 31.14. Samsung Bioepis Co. Ltd.
• 31.15. Lupin Limited

32. Global Eylea Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eylea Market

34. Recent Developments In The Eylea Market

35. Eylea Market High Potential Countries, Segments and Strategies

• 35.1 Eylea Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Eylea Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Eylea Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer